This week, Mark and Margaret speak with Dr. Yulun Wang, Chairman & Chief Executive Officer of InTouch Health. Dr. Wang launched his career at the intersection of healthcare and technology with the founding of Computer Motion, Inc. and the invention of AESOP, the first FDA-cleared surgical robot. Under his leadership, Computer Motion went public in 1997 and later merged with Intuitive Surgical to forge the multi-billion dollar surgical robotics industry. In 2002, Dr. Wang founded InTouch Health, which has been recognized as one of the fastest growing healthcare and technology companies in the world.
The Cutting Edge Career: Dr. Yulun Wang on Surgical Robotics and InTouch Health
Restart
Resume
Share this program on:
Choose a format
Completing the pre-test is required to access this content.
Completing the pre-survey is required to view this content.
Ready to Claim Your Credits?
You have attempts to pass this post-test. Take your time and review carefully before submitting.
Good luck!
Details
Recommended
Details
Overview
This week, Mark and Margaret speak with Dr. Yulun Wang, Chairman & Chief Executive Officer of InTouch Health. Dr. Wang launched his career at the intersection of healthcare and technology with the founding of Computer Motion, Inc. and the invention of AESOP, the first FDA-cleared surgical robot. Under his leadership, Computer Motion went public in 1997 and later merged with Intuitive Surgical to forge the multi-billion dollar surgical robotics industry. In 2002, Dr. Wang founded InTouch Health, which has been recognized as one of the fastest growing healthcare and technology companies in the world.
Title
Share on ReachMD
CloseProgram Chapters
Segment Chapters
Playlist:
Recommended
CME/CE
Advances in MASLD/MASH: Treating the Liver, the Disease, and the Patient – Chair’s Perspective
0.25 credits
<p>Advances in MASLD/MASH: Treating the Liver, the Disease, and the Patient – Chair’s Perspective</p>
CME/CE
IgG4-RD Case Conversations: Retroperitoneal Fibrosis with Refractory Ureteral Involvement
0.50 credits
<p>IgG4-RD Case Conversations: Retroperitoneal Fibrosis with Refractory Ureteral Involvement</p>
MinuteCE®
HF Management for Patients with Comorbid Conditions
0.75 credits
<p>HF Management for Patients with Comorbid Conditions</p>
MinuteCE®
Level Up Your Skills: Tailoring Management of HF
0.75 credits
<p>Level Up Your Skills: Tailoring Management of HF</p>
MinuteCE®
Clinical Conundrums in ARIA: Communicating ARIA Risk with Patients Considering Anti-Aβ Therapy
1.25 credits
<p>Clinical Conundrums in ARIA: Communicating ARIA Risk with Patients Considering Anti-Aβ Therapy</p>
CME/CE
Personalizing Care Within the RCC Treatment Paradigm
1.00 credits
<p>Personalizing Care Within the RCC Treatment Paradigm</p>
Cardiology
Effect of Finerenone on NT-proBNP in HFmrEF/HFpEF: FINEARTS-HF Trial
<p>Effect of Finerenone on NT-proBNP in HFmrEF/HFpEF: FINEARTS-HF Trial </p>
Cardiology
Kidney Risk Stratification in Finerenone Treatment: FINEARTS-HF Trial
<p>Kidney Risk Stratification in Finerenone Treatment: FINEARTS-HF Trial</p>
Register
We’re glad to see you’re enjoying ReachMD…
but how about a more personalized experience?